Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Seetal Dodd, PhD
JCP
Meta-Analysis
N
-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis
April 27, 2016
Michael Berk
,
Gin S. Malhi
,
Seetal Dodd
, et al
JCP
Meta-Analysis
Nocebo Effects in the Treatment of Major Depression: Results From an Individual Study Participant-Level Meta-Analysis of the Placebo Arm of Duloxetine Clinical Trials
June 24, 2015
Alexander Schacht
,
Michael Berk
,
Gin S. Malhi
, et al
JCP
Original Research
Efficiency of N-Acetylcysteine in MDD
June 27, 2014
Read about the Efficacy of N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial.
Michael Berk
,
Gin S. Malhi
,
Seetal Dodd
, et al
JCP
Original Research
Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
October 15, 2009
Michael Berk
,
David de Lucena
,
Brisa Simões Fernandes
, et al
